Trial intelligence / Profile preview

Resveratrol in Insulin Resistance

NCT00654667Phase 2Withdrawn

Sponsor
University of California, San Francisco
Start
May 2007
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of resveratrol in insulin resistance (IR), sponsored by University of California, San Francisco. Planned start May 2007; status: withdrawn.

02

Drugs

resveratrol
03

Conditions

insulin resistance (IR)

Beyond the preview

Go deeper on NCT00654667.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00654667.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call